JNJ

The long path to an effective coronavirus vaccine
The long path to an effective coronavirus vaccine
EP Vantage
vaccines
COVID-19
coronaviruses
Moderna Therapeutics
Shenzhen Genoimmune
Cansino Biologics
Pfizer
BioNTech
Inovio
JNJ
Altimmune
Heat Biologics
iBio
EpiVax
Flag link:
J&J inks Fate deal to move into allogeneic CAR therapies
J&J inks Fate deal to move into allogeneic CAR therapies
Fierce Biotech
JNJ
Fate Therapeutics
CAR NK
CAR-T
cell therapies
drug development
Flag link:
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Fierce Pharma
JNJ
Janssen
China
drug manufacturing
Flag link:
J&J has a COVID-19 vaccine candidate, Phase 1 trials to start in September
J&J has a COVID-19 vaccine candidate, Phase 1 trials to start in September
Marketwatch
JNJ
vaccines
COVID-19
clinical trials
Flag link:
ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease post-surgery
ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease post-surgery
Fierce Pharma
Xarelto
JNJ
ACC
clinical trials
peripheral artery disease
Flag link:
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
Stat
drug development
COVID-19
Italy
JNJ
Janssen
vaccines
Flag link:
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
Flag link:
Q4 Review: Takeaways from the Most Prominent Players in the Medical Device Industry
Q4 Review: Takeaways from the Most Prominent Players in the Medical Device Industry
Medical Devices and Diagnostics Industry
devices
earnings
Abbott Labs
Baxter
Boston Scientific
Edwards Lifesciences
Intuitive Surgical
JNJ
Zimmer Biomet
Stryker
Flag link:
Janssen files MS pill, ahead of FDA decision on BMS’ rival
Janssen files MS pill, ahead of FDA decision on BMS’ rival
Pharmaforum
Janssen
JNJ
multiple sclerosis
MS
FDA
ponesimod
Bristol-Myers Squibb
ozanimod
Flag link:
Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November
Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November
Motley Fool
JNJ
Inovio
Moderna Therapeutics
vaccines
COVID-19
coronaviruses
Flag link:
J&J warns doctors not to count on Prezista as a COVID-19 treatment
J&J warns doctors not to count on Prezista as a COVID-19 treatment
Fierce Pharma
COVID-19
coronaviruses
Prezista
HIV
JNJ
Flag link:
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
Thermo Fisher & J&J Team Up to Develop Lung Cancer Companion Diagnostic
BioSpace
JNJ
Janssen
Thermo Fisher
diagnostics
cancer
clinical trials
Flag link:
J&J’s Experimental Lung Cancer Drug Receives Breakthrough Therapy Designation
J&J’s Experimental Lung Cancer Drug Receives Breakthrough Therapy Designation
BioSpace
Janssen
JNJ
FDA
JNJ-6372
breakthrough therapy
metastatic non-small cell lung cancer
Flag link:
Janssen gets FDA breakthrough therapy status for JNJ-6372 to treat metastatic NSCLC
Janssen gets FDA breakthrough therapy status for JNJ-6372 to treat metastatic NSCLC
Pharmaceutical Business Review
Janssen
JNJ
FDA
JNJ-6372
metastatic non-small cell lung cancer
Flag link:
J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO
J&J's favorite CAR-T developer, currently owned by a Chinese CRO, is laying the groundwork for US IPO
Endpoints
CAR-T
IPOs
GenScript
CROs
China
JNJ
Flag link:
Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success
Johnson & Johnson, Apple’s New Virtual Trial Model Shows Early Enrollment Success
Forbes
JNJ
Apple
Apple Watch
devices
wearables
clinical trials
virtual clinical trials
ECG
Flag link:
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
Marketwatch
Gilead Sciences
GSK
Innovio
JNJ
Moderna Therapeutics
Regeneron
Sanofi
Takeda
Vir Biotchnology
Flag link:
J&J and Apple Begin Enrollment for Heartline Study
J&J and Apple Begin Enrollment for Heartline Study
Medical Devices and Diagnostics Industry
JNJ
iPhone
Apple
mobile apps
atrial fibrillation
stroke
devices
Flag link:
J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit
J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit
Fierce Pharma
JNJ
Remicade
Simponi
kickbacks
whistleblower lawsuits
Flag link:
Johnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19
Johnson & Johnson Expands Pact With U.S. Government to Seek a Treatment for COVID-19
Motley Fool
JNJ
BARDA
COVID-19
coronavirus
antivirals
vaccines
Flag link:

Pages